Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Dementia

• Publication date

  1995-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000106929PMID 7606287
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type.

  1994cited by this paper
• Progestogens: therapeutic and adverse effects in early post-menopausal women.

  1991cited by this paper
• Estrogen Improves Psychological Function in Asymptomatic Postmenopausal Women

  1991cited by this paper
• Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient.

  1990cited by this paper
• Use of progestogens in postmenopausal women.

  1989cited by this paper
• In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type).

  1989cited by this paper
• Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women.

  1988cited by this paper
• Effects of estradiol and dexamethasone on choline acetyltransferase activity in various rat brain regions.

  1988cited by this paper
• Steroid hormones and neurotrophism: Relationship to nerve injury

  1988cited by this paper
• Reductions in acetylcholine and nicotine binding in several degenerative diseases.

  1988cited by this paper
• Acetylcholine and Alzheimer's Disease

  1988cited by this paper
• Controversies concerning the safety of estrogen replacement therapy

  1987cited by this paper
• Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.

  1987cited by this paper
• Climacteric complaints as influenced by progestogens.

  1986cited by this paper
• Estrogen treatment enhances survival of cultured fetal rat amygdala neurons in a defined medium.

  1986cited by this paper
• Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains.

  1986cited by this paper
• Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type.

  1986cited by this paper
• Estrogen replacement therapy in the patient treated for endometrial cancer

  1986cited by this paper
• CYCLICAL MOOD CHANGES AS IN THE PREMENSTRUAL TENSION SYNDROME DURING SEQUENTIAL ESTROGEN‐PROGESTAGEN POSTMENOPAUSAL REPLACEMENT THERAPY

  1985cited by this paper
• Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats.

  1985cited by this paper
• Alzheimer's disease: a disorder of cortical cholinergic innervation.

  1983cited by this paper
• Sex differences in cholinergic enzymes of diagonal band nuclei in the rat preoptic area.

  1983cited by this paper
• Increase in hypothalamic nicotinic acetylcholine receptors in prepuberal female rats administered estrogen.

  1983cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• Immunochemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration.

  1980cited by this paper
• Review of epidemiologic studies of endometrial cancer and exogenous estrogen.

  1979cited by this paper
• Cerebral blood flow in dementia.

  1975cited by this paper
• Human memory and the cholinergic system. A relationship to aging?

  1974cited by this paper
• Oestrogen therapy and the menopausal syndrome.

  1969cited by this paper

• Honey and Alzheimer’s Disease—Current Understanding and Future Prospects

  2023cites this paper
• Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer’s Disease?

  2023cites this paper
• The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease

  2022cites this paper
• Menopause, hormone therapy and cognition: maximizing translation from preclinical research

  2021cites this paper
• DEFERRING MENOPAUSE BY THE ADMINISTRATION OF A LUTEINIZING (56) References Cited HORMONE ANTAGONST U.S. PATENT DOCUMENTS

  2017cites this paper
• Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury

  2017cites this paper
• The Endocrine Dyscrasia that Accompanies Menopause and Andropause Induces Aberrant Cell Cycle Signaling that Triggers Cell Cycle Reentry of Post-mitotic Neurons, Neurodysfunction, Neurodegeneration and Cognitive Disease

  2016cites this paper
• Benefits of Hormone Therapy Estrogens Depend on Estrogen Type: 17β-Estradiol and Conjugated Equine Estrogens Have Differential Effects on Cognitive, Anxiety-Like, and Depressive-Like Behaviors and Increase Tryptophan Hydroxylase-2 mRNA Levels in Dorsal Raphe Nucleus Subregions

  2016cites this paper
• NEUROENDOCRINE CHANGES AND ALZHEIMER DISEASE IN POSTMENOPAUSAL WOMEN

  2015cites this paper
• Nanotherapeutic strategies for the treatment of Alzheimer's disease.

  2015cites this paper
• Nanoparticle-based drug delivery for Alzheimer's disease

  2015cites this paper
• The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.

  2015cites this paper
• Caffeine Reduces Risk of Parkinson’s Disease

  2014cites this paper
• Translational cognitive endocrinology: designing rodent experiments with the goal to ultimately enhance cognitive health in women.

  2013cites this paper
• An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms.

  2013influential citation
• Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

  2013cites this paper
• Risk Reduction of Alzheimer's Disease by Coffee and Caffeine

  2013cites this paper
• Optimization of Menopausal Hormone Therapies for Cognitive and Brain Aging Using a Rat Model

  2013cites this paper
• Age Related Changes in Cognition and Brain: A Focus on Progestogens

  2012cites this paper
• The Effects of Age, Hormone Loss, and Estrogen Treatment on Spatial Cognition in the Rat: Parameters and Putative Mechanisms

  2011influential citation
• olecular mechanisms of steroid receptor-mediated actions by synthetic rogestins used in HRT and contraception

  2011cites this paper
• Tonic Premarin dose-dependently enhances memory, affects neurotrophin protein levels and alters gene expression in middle-aged rats.

  2011cites this paper
• Effects of short-term hormonal replacement on learning and on basal forebrain ChAT and TrkA content in ovariectomized rats.

  2011cites this paper
• Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.

  2011cites this paper
• Neuroscientists as Cartographers: Mapping the Crossroads of Gonadal Hormones, Memory and Age Using Animal Models

  2010cites this paper
• Skin and brain age together: The role of hormones in the ageing process.

  2010cites this paper
• A component of Premarin(®) enhances multiple cognitive functions and influences nicotinic receptor expression.

  2010cites this paper
• Impact of the hypothalamic-pituitary-adrenal/gonadal axes on trajectory of age-related cognitive decline.

  2010cites this paper
• The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical.

  2010cites this paper
• Medroxyprogesterone acetate impairs memory and alters the GABAergic system in aged surgically menopausal rats.

  2010cites this paper
• Hormonal Influences on Brain Aging and Age-Related Cognitive Decline

  2009cites this paper
• Premarin improves memory, prevents scopolamine-induced amnesia and increases number of basal forebrain choline acetyltransferase positive cells in middle-aged surgically menopausal rats.

  2009cites this paper
• Hormone replacement therapy to maintain cognitive function in women with dementia.

  2009cites this paper
• Conjugated equine estrogen enhances rats' cognitive, anxiety, and social behavior

  2008cites this paper
• The use of multi-sensory stimulation to improve functional performance in older people with dementia : a randomised single blind trial

  2007cites this paper
• Effects of Hormone Replacement Therapy and Aging on Cognition: Evidence for Executive Dysfunction

  2007cites this paper
• Oxidative stress: A bridge between Down's syndrome and Alzheimer's disease

  2007cites this paper
• Effects of estrogens on cholinergic neurons in the rat basal nucleus.

  2007cites this paper
• Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease.

  2007cites this paper
• Estrogen and performance in recognition memory for olfactory and visual stimuli in females diagnosed with Alzheimer's disease

  2006cites this paper
• Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle‐aged ovariectomized female rats

  2006cites this paper
• Estrogens in Alzheimer’s Disease: A Clinical and Neurobiological Perspective

  2005cites this paper
• Neuroprotective effects of female sex steroids in humans: current controversies and future directions.

  2005cites this paper
• The Effects of Estrogens on Cognition and Alzheimer's Dementia

  2005cites this paper
• Does estrogen replacement therapy protect against Alzheimer's disease?

  2005cites this paper
• Estrogens and brain function.

  2005cites this paper
• Neurotropic and psychotropic action of estrogens: implications for Alzheimer's disease

  2005cites this paper
• Inter- and intraindividual variability in recognition memory: effects of aging and estrogen use.

  2004cites this paper
• Letters to the editors

  2004cites this paper
• Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.

  2004cites this paper
• Effects of estradiol and progesterone on radial maze performance in middle-aged female rats fed a low-calcium diet.

  2004cites this paper
• Hormonal and non-hormonal factors associated with cognition in post-menopausal women

  2004cites this paper
• Age-related deficits as working memory load increases: relationships with growth factors.

  2003cites this paper
• Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice.

  2003cites this paper
• Can testosterone replacement decrease the memory problem of old age?

  2003cites this paper
• Review of dementia.

  2003cites this paper
• Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory.

  2003cites this paper
• Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome.

  2003cites this paper
• ReviewGenetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease

  2003cites this paper
• The measurement of adenosine and estrogen receptor expression in rat brains following ovariectomy using quantitative PCR analysis.

  2003cites this paper
• Estrogen and non-feminizing estrogen for Alzheimer's disease.

  2003cites this paper
• Research report Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome

  2003cites this paper
• Relationship of endogenous levels of sex hormones to cognition and depression in frail, elderly women.

  2002cites this paper
• Selective estrogen receptor modulators as a new therapeutic drug group: concept to reality in a decade.

  2002cites this paper
• The Effects of Estrogen Replacement Therapy on Neuropsychological Functioning in Postmenopausal Women With and Without Dementia: A Critical and Theoretical Review

  2002cites this paper
• Estrogen induces a rapid increase of calcium-calmodulin-dependent protein kinase II activity in the hippocampus.

  2002cites this paper
• Oestrogen has neuroprotective effects and may reduce the risk of Alzheimer’s disease

  2002cites this paper
• Estrogen and Alzheimer’s Disease

  2002cites this paper
• Gliosis in relation to Alzheimer's hallmark lesions in aging and Alzheimer's disease

  2002cites this paper
• Gender differences in the cognitive impairment in Alzheimer's disease

  2002cites this paper
• Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate.

  2002cites this paper
• Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease.

  2002cites this paper
• Estrogen Replacement Therapy for Alzheimer Disease in Postmenopausal Women

  2002cites this paper
• Estrogen replacement therapy for cognitive benefits: viable treatment or forgettable "senior moment"?

  2002cites this paper
• Brain aging and Alzheimer's disease; use it or lose it.

  2002cites this paper
• Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits

  2002cites this paper
• Hormone replacement therapy to maintain cognitive function in women with dementia.

  2002cites this paper
• Relationships of sex hormone levels to dependence in activities of daily living in the frail elderly.

  2001cites this paper
• Alzheimer's disease and estrogen.

  2001cites this paper
• Neuroactive steroids and central nervous system disorders.

  2001cites this paper
• Estrogens and Alzheimer's Disease

  2001cites this paper
• Effects of blood estrogen level on cortical activation patterns during cognitive activation as measured by functional MRI.

  2001cites this paper
• HRT in the third millennium.

  2001cites this paper
• Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons

  2001cites this paper
• Estrogen Replacement Therapy for the Potential Treatment or Prevention of Alzheimer's Disease

  2001cites this paper
• Gender, aging, health and society.

  2001cites this paper
• 3 SEX HORMONE THERAPY FOR

  2000cites this paper
• The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.

  2000cites this paper
• Endogenous estrogen levels and Alzheimer’s disease among postmenopausal women

  2000cites this paper
• Estrogen use, APOE, and cognitive decline

  2000cites this paper
• Estrógenos y enfermedad de Alzheimer: bases, promesas y realidades

  2000cites this paper
• The Smarter Sex: A Critical Review of Sex Differences in Intelligence

  2000cites this paper
• Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats.

  2000cites this paper
• Use of Estrogens for the Prevention and Treatment of Alzheimer’s Disease

  2000cites this paper
• Estrogen for Alzheimer’s disease in women

  2000cites this paper
• HRT and Brain Function — Clinical Aspects

  2000cites this paper
• Memory Functioning Among Midlife Women: Observations From the Seattle Midlife Women's Health Study

  2000cites this paper
• CHAPTER 21 – Estrogen Therapy and the Brain

  2000cites this paper
• Effects of estrogen on cognition, mood, and cerebral blood flow in AD

  2000cites this paper
• The Gottfries-Bråne-Steen Scale: Validity, Reliability and Application in Anti-Dementia Drug Trials

  2000cites this paper